September 10th – September 12th 2019

NEW DIRECTIONS IN IMMUNO-ONCOLOGY

EMERGING BIOLOGY FOR THERAPY AND STRATIFICATION

CRUK_ECMC

Registration is now open! CPD Points for Specialists and Trainees

00
Days
00
Hours
00
Minutes
00
Seconds

Deadline for abstract submission has now passed.

What is happening? King’s Health Partners and Birmingham CRUK Centres and ECMC; Immune-Oncology Conference.

This timely conference brings together the fundamental and clinical research communities working at the cutting edge of immuno-oncology interventions and their stratified application. Two and half days of stimulating sessions and debates, followed by parallel workshops on the last afternoon.

Abstract submissions offer the opportunity to present exciting new findings in poster sessions or as an invited short talk and is open to researchers at every career stage.

The meeting provides to all the speakers and delegates Continuing Professional Development (CPD) credits (Clinical Genetics, Haematology
Immunology and Medical Oncology).

This International Cancer Immunology Conference supported through the Cancer Research UK (CRUK) Centre Network and the Experimental Cancer Medicine Centres (ECMC) Network. Our intention is to bring together a broad cross-section of the community of researchers and clinicians working at the cutting edge of immune-oncology interventions and their stratified application. The conference will cover both the immediate and longer-term prospects in the development pipeline and the means through which we might better determine effective deployment of these interventions, including technology platforms and the ‘big data’ analytical hurdles.    

Event Speakers

Prof Julie Brahmer

Keynote speaker, Johns Hopkins, United States

Prof Johanna Olweus

Oslo University, Norway

Dr Jonathan Irish

Vanderbilt University, United States

Dr Sophie Papa

King’s College London, UK

Abstract submission for participants

We invite all participants to submit scientific abstracts to be presented as oral or poster presentations.

Abstract submission deadline: The deadline is now passed.

Programme of events

The conference will cover both the immediate and longer-term prospects in the development pipeline and the means through which we might better determine effective deployment of these interventions, including technology platforms and the ‘big data’ analytical hurdles.

The first day of the joint programme is the Experimental Cancer Medicine Centres (ECMC) national network day, designed to foster new links between lab immunology and early phase investigators.

The focus of the second day is the precision medicine and the role of cutting-edge omics in cancer immunology and immunotherapy.

“Big Data” in cancer immunology and potential clinical applications are the focuses of day 3. There will also be three optional hands-on workshops in the afternoon.

Our sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Workshop Sponsors​

General Sponsors

Where to find us... Get Direction to the Bush House East Wing

Bush House South East Entrance, King’s College London

Bush House, 30 Aldwych, London, WC2B 4BG
England, UK

 

Contact Info:

Phone: +44 (0)20 7836 5454

Email: immunologyconference@kcl.ac.uk

Bush House is a Grade II listed building at the southern end of Kingsway between Aldwych and the Strand in London.

We have now moved staff and students into these new buildings, which provide a home for many of our academic departments, as well as state-of-the-art learning and social spaces and enhanced student facilities.

Bush House North & South Wings form the centre of Bush House buildings. The former home of the BBC World Service, they feature the iconic Kingsway portico entrance with its neoclassical columns and statues, as well as the building’s main lobby.

Useful links

Partner: Cancer Research UK

Cancer affects people all over the world. To beat it, we need to work together. Cancer Research UK is the largest independent funder of cancer research in the world.

Partner: CRUK - City of London Cancer Centre

The Cancer Research UK City of London (CoL) Centre is a world class hub for cancer biotherapeutics bringing together researchers from: The Francis Crick Institute, UCL, Barts / Queen Mary University of London and King’s College London.

Partner: Birmingham Cancer Centre

The Birmingham Cancer Research UK Centre is a partnership between University Hospitals Birmingham, the University of Birmingham and Cancer Research UK.

For any additional information, please get in touch